A Study of MT-4561 in Patients With Various Advanced Solid Tumors
Tanabe Pharma America, Inc.
Tanabe Pharma America, Inc.
Turning Point Therapeutics, Inc.
Marengo Therapeutics, Inc.
Hoffmann-La Roche
Numab Therapeutics AG
Intensity Therapeutics, Inc.
Vaccinex Inc.
Simcha IL-18, Inc.
Atara Biotherapeutics
Cancer Research UK
Evopoint Biosciences Inc.
Icahn School of Medicine at Mount Sinai
Kineta Inc.
The University of Texas Health Science Center at San Antonio
Genocea Biosciences, Inc.
Dana-Farber Cancer Institute
University of Pittsburgh